Scinai Immunotherapeutics (SCNI) Exchange Rate Effect (2018 - 2026)
Scinai Immunotherapeutics (SCNI) posted Exchange Rate Effect of $3.1 million for Q1 2026, up 361.46% sequentially from -$1.2 million in Q2 2025, and up 171.02% YoY from $1.1 million in Q1 2025.
Scinai Immunotherapeutics (SCNI) Exchange Rate Effect (2018 - 2026) Analysis & Trends
Scinai Immunotherapeutics has reported Exchange Rate Effect for 9 years, with the latest figure at $3.1 million in Q1 2026.
- Quarterly Exchange Rate Effect rose 171.02% year-over-year to $3.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $3.1 million (up 180.35% YoY) and the FY2025 annual result came in at $1000.0, up 111.11% from the prior year.
- Exchange Rate Effect climbed to $3.1 million in Q1 2026 per SCNI's latest filing, from -$1.2 million in the prior quarter.
- Over five years, Exchange Rate Effect peaked at $5.0 million in Q1 2024 and troughed at -$4.8 million in Q2 2024.
- A 5-year average of $191000.0 and a median of -$41000.0 in 2023 frame the typical range for Exchange Rate Effect.
- The widest YoY moves for Exchange Rate Effect: up 2316.96% in 2024, down 11717.07% in 2024.
- Over 5 years, Exchange Rate Effect stood at -$151000.0 in 2022, then surged by 90.73% to -$14000.0 in 2023, then surged by 114.29% to $2000.0 in 2024, then sank by 59650.0% to -$1.2 million in 2025, then jumped by 361.46% to $3.1 million in 2026.
- According to Business Quant data, Exchange Rate Effect over the past three periods registered $3.1 million, -$1.2 million, and $1.1 million for Q1 2026, Q2 2025, and Q1 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Exchange Rate Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.97 Bn | 132.12 Bn | 2.84 Bn | -3.70 Mn |
| 2 | Regeneron Pharmaceuticals | 86.64 Bn | 78.64 Bn | 3.93 Bn | -300,000.00 |
| 3 | Argenx Se | 65.55 Bn | 60.37 Bn | 1.37 Bn | - |
| 4 | Moderna | 61.26 Bn | 56.12 Bn | 52.00 Mn | -2.00 Mn |
| 5 | BeOne Medicines | 42.30 Bn | 37.20 Bn | 1.53 Bn | 19.84 Mn |
| 6 | Alnylam Pharmaceuticals | 31.66 Bn | 28.35 Bn | 992.69 Mn | -2.45 Mn |
| 7 | BioNTech SE | 28.68 Bn | 10.29 Bn | 668.28 Mn | 1.63 Mn |
| 8 | Insmed | 27.54 Bn | 26.38 Bn | 358.27 Mn | -287,000.00 |
| 9 | Royalty Pharma | 27.26 Bn | 26.42 Bn | - | - |
| 10 | Scinai Immunotherapeutics | 12.84 Mn | -3.10 Bn | -1.12 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 3.11 Mn |
| Mar 31, 2026 | 3.11 Mn |
| Jun 30, 2025 | -1.19 Mn |
| Jun 30, 2025 | -1.19 Mn |
| Mar 31, 2025 | 1.15 Mn |
| Mar 31, 2025 | 1.15 Mn |
| Dec 31, 2024 | 2,000.00 |
| Dec 31, 2024 | 2,000.00 |
| Sep 30, 2024 | -132,000.00 |
| Sep 30, 2024 | -132,000.00 |
| Jun 30, 2024 | -4.85 Mn |
| Jun 30, 2024 | -4.85 Mn |
| Mar 31, 2024 | 4.97 Mn |
| Mar 31, 2024 | 4.97 Mn |
| Dec 31, 2023 | -14,000.00 |
| Dec 31, 2023 | -14,000.00 |
| Sep 30, 2023 | 7,000.00 |
| Sep 30, 2023 | 7,000.00 |
| Jun 30, 2023 | -41,000.00 |
| Jun 30, 2023 | -41,000.00 |